Literature DB >> 6188828

Endotoxin-induced interferon synthesis in macrophage cultures.

E A Havell, G L Spitalny.   

Abstract

Pure cultures of murine bone marrow-derived macrophages produce interferon (IFN) after exposure to endotoxin. The levels of endotoxin-induced IFN were enhanced 5- to 20-fold by pretreating (priming) macrophages with murine interferons produced by either NDV-induced L cells, which consisted of a mixture of IFN alpha and IFN beta, or IFN gamma produced by spleen cells stimulated with phytohemagglutinin. Studies conducted on the kinetics of IFN release from endotoxin-induced macrophages demonstrated that peak synthesis occurred within 2-4 hr and was completed 6 hr after the start of treatment. The addition of actinomycin D to macrophages, up to 1 hr after exposure to endotoxin, completely inhibited release of interferon, thus indicating that gene transcription was required for interferon synthesis. The inclusion of cycloheximide in the medium of endotoxin or Poly(I) X Poly(C)-induced macrophages, although inhibiting 90% of protein synthesis, resulted in a superinducing effect, in that induced macrophages treated with cycloheximide produced higher levels of IFN than macrophages not treated with the inhibitor of protein synthesis. Antigenic characterization of macrophage IFNs revealed that endotoxin-induced IFN was neutralized to a higher degree than virus-induced IFNs derived from either macrophages or L cells.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6188828

Source DB:  PubMed          Journal:  J Reticuloendothel Soc        ISSN: 0033-6890


  13 in total

1.  Identification and characterization of lipopolysaccharide-binding proteins on human peripheral blood cell populations.

Authors:  J L Halling; D R Hamill; M G Lei; D C Morrison
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

2.  Synthesis and secretion of interferon by murine fibroblasts in response to intracellular Listeria monocytogenes.

Authors:  E A Havell
Journal:  Infect Immun       Date:  1986-12       Impact factor: 3.441

3.  Endogeneous interferon alpha/beta produced by murine Kupffer cells augments liver-associated natural killing activity.

Authors:  M Werner-Wasik; W von Muenchhausen; J P Nolan; S A Cohen
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

4.  Bacterial lipopolysaccharide and gamma interferon induce transcription of beta interferon mRNA and interferon secretion in murine macrophages.

Authors:  S Gessani; F Belardelli; A Pecorelli; P Puddu; C Baglioni
Journal:  J Virol       Date:  1989-06       Impact factor: 5.103

5.  Production of a neutrophil chemotactic factor by endotoxin stimulated alveolar macrophages in vitro.

Authors:  M C Snella
Journal:  Br J Exp Pathol       Date:  1986-12

6.  Necessity and sufficiency of beta interferon for nitric oxide production in mouse peritoneal macrophages.

Authors:  X Zhang; E W Alley; S W Russell; D C Morrison
Journal:  Infect Immun       Date:  1994-01       Impact factor: 3.441

7.  A synthetic analog of the 3-deoxy-D-manno-2-octulosonic acid disaccharide moiety of rough-type endotoxins does not bind to mouse peritoneal macrophages and human monocytes.

Authors:  R Girard; T Pedron; P Kosma; R Chaby
Journal:  Infect Immun       Date:  1993-09       Impact factor: 3.441

8.  Priming of human monocytes for enhanced lipopolysaccharide responses: expression of alpha interferon, interferon regulatory factors, and tumor necrosis factor.

Authors:  M P Hayes; K C Zoon
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

9.  Serum-independent binding of lipopolysaccharide to human monocytes is trypsin sensitive and does not involve CD14.

Authors:  I Corrales; A J Weersink; J Verhoef; K P van Kessel
Journal:  Immunology       Date:  1993-09       Impact factor: 7.397

10.  Endogenous interferon alpha/beta produced by Kupffer cells inhibits interleukin-1, tumor necrosis factor alpha production and interleukin-2-induced activation of nonparenchymal liver cells.

Authors:  S P Tzung; S A Cohen
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.